ResMed | RMD - 流动负债

金融业

USD

USD 8.78B

现金及等价物

USD 1.66B

USD 551.67M

USD 4.06B

USD 1.35B

USD 847.72M

股息收益率

1.04

USD 505.67M

USD 547.48M

10.6K

EPS每股收益

USD 2.86

股本和储备

USD 6.49B

USD 890.98M

债务利息支出

USD 8.79M

USD 59K

USD 404.17M

USD 30.94B

USD 398.73M

USD 925.74M

USD 505.67M

普通股股本

USD 190.83M

21.21

USD 496.15M

USD 1.4B

销售和管理费用

USD 279.8M

USD 911.88M

贸易债权人

USD 273.3M

应收帐款人

USD 998.84M

	流动负债	更改		日
Ansell	USD 468.9M		53.1M	2025-12
Artivion	USD 92.7M		8.86M	2026-03
AtriCure	USD 73.19M		8.33M	2026-03
Baxter International	USD 3.69B		723M	2026-03
Cochlear	AUD 558.9M		43.4M	2025-12
Cooper Companies	USD 1.6B		482.9M	2025-12
CSL	USD 4.61B		207M	2025-12
Dexcom	USD 2.22B		81.3M	2026-03
Edwards Lifesciences	USD 1.41B		404.7M	2026-03
Fisher Paykel Healthcare	NZD 471.3M		29.1M	2025-12
Globus Medical	USD 482.46M		16.04M	2026-03
Haemonetics	USD 282.6M		257.27M	2026-03
Idexx Laboratories	USD 1.3B		151.04M	2026-03
Inogen	USD 64.94M		2.12M	2025-09
Insulet	USD 687.5M		7.4M	2026-03
Integra LifeSciences	USD 346.85M		109.14M	2026-03
Intuitive Surgical	USD 2.51B		3.2M	2026-03
Masimo	USD 325.4M		46.2M	2026-03
Medtronic	USD 9.5B		440M	2025-12
Philips	EUR 7.43B		78M	2026-03
Ramsay Health Care	AUD 3.95B		514.2M	2025-12
ResMed	USD 1.35B		103.1M	2026-03
Sigma Healthcare	AUD 1.7B		1.33B	2025-12
Sonic Healthcare	AUD 2.23B		92.84M	2024-12
Steris	USD 1.14B		222.7M	2026-03
Teleflex	USD 728.05M		33.98M	2026-03
Thermo Fisher Scientific	USD 14.62B		568M	2026-03